HomeRNTX • NASDAQ
add
Rein Therapeutics Inc
Previous close
$1.08
Day range
$1.11 - $1.23
Year range
$1.05 - $4.40
Market cap
27.50M USD
Avg Volume
113.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.87M | -23.98% |
Net income | -6.82M | 23.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.87M | 23.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.72M | -73.89% |
Total assets | 57.48M | -47.46% |
Total liabilities | 9.47M | 12.97% |
Total equity | 48.01M | — |
Shares outstanding | 23.31M | — |
Price to book | 8.31 | — |
Return on assets | -29.85% | — |
Return on capital | -35.09% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.82M | 23.71% |
Cash from operations | -6.42M | 23.50% |
Cash from investing | — | — |
Cash from financing | 4.71M | -74.20% |
Net change in cash | -1.71M | -117.28% |
Free cash flow | -2.30M | 57.73% |
About
Founded
2001
Headquarters
Website
Employees
11
